This closed-door gathering that started Monday comes about a year before Xi is expected to secure a fourth term and personnel changes to key leadership bodies.
A new study reveals a dust-reddened quasar from a time when the universe was less than a billion years old. Located at a redshift of 6.5488, the object J1440+0019 contains a rapidly accreting supermassive black hole with a mass of about 1.1 billion suns. The paper was posted to the arXiv preprint server on Oct. 9.
Can crowds of people trading on what they believe will happen collectively predict the future? A new Tel Aviv University study of more than 1 million forecasts suggests that they often come remarkably close. But when it comes to certain events, from international conflicts to elections, the odds may tell a different story.
Bolsonaro quickly refused to concede defeat and asked for the election results to be annulled after an evening of chaos at some polling places that followed a last-minute decision to extend voting by two hours.
Eni raises its 2026 cash flow outlook, boosts shareholder payouts to euro 8.2B and targets upstream growth while maintaining disciplined capital spending.
US equity futures waver ahead of a week full of tech earnings and central bank rate decisions as oil retreats from a six-month high. Brazilian markets brace for a selloff as President Luiz Inácio Lula da Silva wins a record fourth term in a runoff election and opponent Flávio Bolsonaro calls for the vote to be annulled. Elon Musk says SpaceX has closed a $40 billion debt deal to pay for AI chips. Yohanan Plesner, President of the Israel Democracy Institute, joins "Bloomberg Brief" to looks ahead to Israel's election between Prime Minister Netanyahu and Gadi Eisenkot. Amy Wu Silverman of RBC Capital Markets previews the week's big tech earnings. (Source: Bloomberg)
Screencaps highlights Kylie Cantrall's World Series national anthem in Milwaukee, where fans are comparing her voice to Whitney Houston's iconic rendition.
(RTTNews) - Medicus Pharma (MDCX) announced that it has regained compliance with Nasdaq's minimum bid price requirement, resolving a listing-related compliance issue for the biotechnology company.
Medicus said it received written notification from Nasdaq on October 23 confirming